CRIS Current Research Information System

TADOLINI, MARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.491
AS - Asia 4.431
EU - Europa 2.721
SA - Sud America 308
AF - Africa 281
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.249
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.401
SG - Singapore 1.259
CN - Cina 1.121
VN - Vietnam 945
GB - Regno Unito 805
SE - Svezia 388
IT - Italia 382
DE - Germania 326
HK - Hong Kong 287
BR - Brasile 221
KR - Corea 198
FR - Francia 190
IN - India 183
RU - Federazione Russa 173
BD - Bangladesh 137
IE - Irlanda 93
JP - Giappone 87
ZA - Sudafrica 81
NL - Olanda 75
FI - Finlandia 73
CI - Costa d'Avorio 68
SC - Seychelles 56
CA - Canada 48
EE - Estonia 43
UA - Ucraina 40
AR - Argentina 39
ID - Indonesia 36
TG - Togo 32
PH - Filippine 28
TW - Taiwan 24
MX - Messico 23
CH - Svizzera 21
AT - Austria 20
JO - Giordania 19
TH - Thailandia 17
BE - Belgio 16
IQ - Iraq 15
PK - Pakistan 15
BG - Bulgaria 14
PL - Polonia 14
TR - Turchia 14
AU - Australia 13
EC - Ecuador 13
GR - Grecia 10
MA - Marocco 8
NG - Nigeria 8
CL - Cile 7
CO - Colombia 7
ES - Italia 7
MY - Malesia 7
ET - Etiopia 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
DZ - Algeria 5
LT - Lituania 5
PE - Perù 5
PY - Paraguay 5
VE - Venezuela 5
BO - Bolivia 4
DO - Repubblica Dominicana 4
JM - Giamaica 4
RO - Romania 4
AL - Albania 3
AZ - Azerbaigian 3
EG - Egitto 3
IL - Israele 3
IR - Iran 3
KE - Kenya 3
LB - Libano 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
CY - Cipro 2
CZ - Repubblica Ceca 2
EU - Europa 2
KZ - Kazakistan 2
LS - Lesotho 2
MD - Moldavia 2
MM - Myanmar 2
NO - Norvegia 2
PT - Portogallo 2
SI - Slovenia 2
TN - Tunisia 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BZ - Belize 1
CD - Congo 1
CG - Congo 1
CM - Camerun 1
GH - Ghana 1
GT - Guatemala 1
HU - Ungheria 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
Totale 12.235
Salva come PNG Salva come JPEG
Città #
Singapore 865
Southend 745
Ashburn 526
Fairfield 379
Hefei 377
Santa Clara 319
Hong Kong 277
Ho Chi Minh City 251
San Jose 239
Chandler 208
Hanoi 208
Wilmington 186
Houston 185
Seoul 185
Woodbridge 178
Seattle 172
Cambridge 147
Beijing 134
Princeton 128
Ann Arbor 117
Dallas 103
Boardman 100
Dublin 93
Dong Ket 88
Lauterbourg 81
Tokyo 79
New York 76
Bologna 74
Abidjan 68
Council Bluffs 64
Los Angeles 64
Buffalo 58
Nanjing 56
Helsinki 55
Frankfurt am Main 50
Milan 49
Westminster 46
Bengaluru 40
Padova 40
Dearborn 35
Lomé 32
San Diego 32
Saint Petersburg 30
Haiphong 29
Johannesburg 29
Berlin 28
Nuremberg 26
Redondo Beach 26
São Paulo 25
Da Nang 24
The Dalles 23
Jakarta 22
Rome 20
Toronto 20
Bern 19
Amman 18
Des Moines 16
Nanchang 16
Rimini 16
Brussels 15
Falls Church 15
Amsterdam 14
Chicago 14
Hebei 14
Phoenix 14
Shanghai 14
Sofia 14
Tongling 14
Atlanta 13
Changsha 13
Falkenstein 13
Guangzhou 13
Hải Dương 13
Jinan 13
Shenyang 13
Yubileyny 13
Bremen 12
San Francisco 12
Bangkok 11
Lappeenranta 11
Moscow 11
Munich 11
Redwood City 11
Tianjin 11
Zhengzhou 11
Biên Hòa 10
London 10
Washington 10
Can Tho 9
Chennai 9
Montreal 9
Orem 9
Turin 9
Warsaw 9
Chengdu 8
Denver 8
Jacksonville 8
Jiaxing 8
Naples 8
Quận Bình Thạnh 8
Totale 8.061
Salva come PNG Salva come JPEG
Nome #
Trend of microbiologically-confirmed tuberculosis in a low-incidence setting with high immigration rates 436
Spinal tuberculosis: Proposed spinal infection multidisciplinary management project (SIMP) flow chart revision 254
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 249
First evaluation of QuantiFERON-TB gold plus performance in contact screening 195
COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy 187
IGRA test for TB in COVID-19: role of corticosteroids 185
Diagnosis of smear-negative tuberculosis is greatly improved by Xpert MTB/RIF 184
TB consilia and quality of tuberculosis management 181
Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment 178
Evaluation of trace calls by Xpert MTB/RIF ultra for clinical management in low TB burden settings 177
The International Journal of Tuberculosis and Lung Disease (IJTLD) 173
Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review 173
Clinical impact of reninangiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for coronavirus disease 2019 172
Vaccination in post-tuberculosis lung disease management: A review of the evidence 170
Multidetector CT urography in urogenital tuberculosis: use of reformatted images for the assessment of the radiological findings. A pictorial essay 170
World Tuberculosis Day 2023 theme “Yes! We Can End TB!” 169
Effectiveness and safety of meropenem/ clavulanate-containing regimens in the treatment of MDR- and XDR-TB 169
A multidrug resistant tuberculosis case treated with continuous infusion of meropenem in outpatient care 169
A new free-cost e-service supporting clinicians to manage their difficult-to-treat tuberculosis cases: The European respiratory society-World Health Organization tuberculosis consilium 168
Tuberculosis elimination: Theory and practice in Europe 166
Update of drug-resistant tuberculosis treatment guidelines: A turning point 163
Predictors of time to sputum smear conversion in patients with pulmonary tuberculosis under treatment 162
Membranoproliferative glomerulonephritis associated with human immunodeficiency virus, hepatitis B and hepatitis C virus coinfection: case report and literature review. 160
Overview of fever of unknown origin in adult and paediatric patients 160
Challenging MDR-TB clinical problems – The case for a new Global TB Consilium supporting the compassionate use of new anti-TB drugs 160
Comparison of effectiveness and safety of imipenem/clavulanate-versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB 159
Combined use of delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis: A systematic review 159
Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine 158
Active tuberculosis, sequelae and COVID-19 co-infection: First cohort of 49 cases 157
Crossborder travel and multidrugresistant tuberculosis (MDRTB) in Europe 155
Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: Early experiences and challenges 154
Systematic Tuberculosis Screening in Asylum Seekers in Italy 154
Seventeen cases of Mycobacterium marinum infection in Italy: A multicenter retrospective study 153
Clinical standards for the management of adverse effects during treatment for TB 152
Policy and programmatic directions for the Lesotho tuberculosis programme: Findings of the national tuberculosis prevalence survey, 2019 151
Clinical standards for drug-susceptible pulmonary TB 151
Clinical standards for the dosing and management of TB drugs 151
The first population-based national tuberculosis prevalence survey in Ethiopia, 2010-2011 149
Country-specific lockdown measures in response to the COVID-19 pandemic and its impact on tuberculosis control: a global study 148
Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort 146
Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis 145
Socioeconomic status and biomedical risk factors in migrants and native tuberculosis patients in Italy 144
First independent evaluation of QuantiFERON-TB Plus performance 143
Compassionate and optimum use of new tuberculosis drugs 143
Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimine 143
How We Treat Drug-Susceptible Pulmonary Tuberculosis: A Practical Guide for Clinicians 142
Combining bedaquiline and delamanid to treat multidrug-resistant tuberculosis 141
Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): A study protocol of a prospective multicentre cohort study 139
Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: A systematic review 138
Quantiferon-TB performs better in children, including infants, than in adults with active tuberculosis: a multicentre study 137
Healthcare seeking patterns for TB symptoms: Findings from the first national TB prevalence survey of South Africa, 2017–2019 133
Do we need a new Fleming époque: The nightmare of drug-resistant tuberculosis 132
Recommendations for treating children with drug-resistant tuberculosis 132
Human herpesvirus-8-related Kaposi’s sarcoma after liver transplantation successfully treated with cidofovir and liposomal daunorubicin. 132
Prevalence of bacteriologically confirmed pulmonary tuberculosis in South Africa, 2017-19: a multistage, cluster-based, cross-sectional survey 130
New and repurposed drugs for pediatric multidrug-resistant tuberculosis practice-based recommendations 129
Recommendations for the diagnosis of pediatric tuberculosis 129
Paediatric tuberculosis in Europe: Lessons from Denmark and inclusive strategies to consider 124
First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline 124
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort 123
WHO strategies for the programmatic management of drug-resistant tuberculosis 122
ERS/WHO Tuberculosis Consilium: Reporting of the initial 10 cases 122
Supporting clinical management of the difficult-to-treat TB cases: The ERS-WHO TB Consilium 122
Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January–April 2020 122
ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: Case study of compassionate delamanid use 119
Recommendations Concerning the Therapeutic Approach to Immunocompromised Children with Tuberculosis 115
Faster for less: The new "shorter" regimen for multidrug-resistant tuberculosis 115
Comprehensive Whole Genome Sequencing Dataset of Mycobacterium tuberculosis Strains Collected Across Italy 115
Recommendations Concerning the First-Line Treatment of Children with Tuberculosis 113
Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts 109
Introduction of bedaquiline for the treatment of multi-drug resistant tuberculosis at country level: implementation plan 105
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: First global report 101
On tuberculosis and COVID-19 co-infection 97
National population-based tuberculosis prevalence survey in Ghana, 2013 96
A new free-cost e-service supporting clinicians to manage their difficult-to-treat TB cases: The ERS-WHO TB consilium 89
TB mortality in low-incidence countries: can we reduce it further? 88
National tuberculosis prevalence surveys in Africa, 2008–2016: an overview of results and lessons learned 83
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study 77
Gauging the impact of the COVID-19 pandemic on tuberculosis services: A global study 77
Reducing tuberculosis transmission: A consensus document from the World Health Organization Regional Office for Europe 75
Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyond 70
We cannot eliminate TB without TB drugs: a wake-up call from Italy 68
COVID-19 Hampered Diagnosis of TB Infection in France, Italy, Spain and the United Kingdom 67
High TB burden and low notification rates in the Philippines: The 2016 national TB prevalence survey 66
null 64
Ten common myths about drug-susceptible TB 60
TB outpatient care in a high-income, low-incidence country 60
Consolidated guidance on tuberculosis data generation and use. Module 3. National tuberculosis prevalence surveys. Geneva: World Health Organization; 2025. Licence: CC BY-NC-SA 3.0 IGO 58
National TB prevalence surveys in the COVID-19 era 58
null 57
Efficacy, safety, and tolerability of a 24-month treatment regimen including delamanid in a child with extensively drug-resistant tuberculosis: A case report and review of the literature 50
Post-tuberculosis lung disease: a guide for clinicians 23
Impact of the COVID-19 pandemic on tuberculosis services in a rural area of Senegal 12
Clinical Images: A thorn injury, a sea‐borne culprit, and a tenosynovitis dilemma 10
Totale 12.515
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.002
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.002
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021217 0 0 0 0 0 0 0 0 0 0 0 217
2021/20221.145 69 72 79 116 109 54 28 79 30 101 210 198
2022/20231.111 84 134 66 137 104 100 42 63 234 19 77 51
2023/2024470 30 62 37 50 53 108 14 21 31 36 16 12
2024/20252.082 36 272 122 120 407 119 131 60 23 109 143 540
2025/20264.936 474 589 557 375 498 275 406 136 712 328 364 222
Totale 12.515